Since his first article in 2001, Dr. Herrera has delivered a total of 48 scientific reports (41 research articles, 5 reviews, 2 book chapters; 6 as corresponding author, 12 as first author; 10 as second author; 20 as a co-author), which were cited more than 4300 times (H factor: 27; see for updated details). Dr. Herrera published in high IF journals within his field, such as Cell Death Diff. (IF: 15.828), Nature Comm. (IF: 14.919), Cancer Res. (IF: 12.701), J. Pineal Res. (IF: 13.007, Top Five Ranking in Physiology and Top ten in Endocrinology and Metabolism), Cell Mol Life Sci (IF: 9.261), Free Rad. Biol. Med. (IF: 7.376), Hum Mol Gen (IF: 6.150) or J. Biol. Chem. (IF: 5.157). Thirty-eight of these articles were published in journals within the 1st quartile IF of their respective fields.

Full CV can be consulted online in different versions:

ORCID: 0000-0002-9596-9353

ResearcherID: F-2261-2011

Scopus Author ID: 7102348620

CiênciaID: 0219-50C3-279B

Articles in International Peer-reviewed Journals

46. Moreira GG, Cantrelle FX, Quezada A, Carvalho FS, Cristóvão JS, Sengupta U, Puangmalai N, Carapeto AP, Rodrigues MS, Cardoso I, Fritz G, Herrera F, Kayed R, Landrieu I, Gomes CM (2021). Dynamic interactions and Ca2+-binding modulate the holdase-type chaperone activity of S100B preventing tau aggregation and seeding. Nat Commun 12, 6292 (2021).
45. Diallo M and Herrera F (2021), The role of understudied post-translational modifications for the behavior and function of Signal Transducer and Activator of Transcription 3. Review. FEBS J.
44. Rodríguez C, Puente‐Moncada N, Reiter RJ, Sánchez‐Sánchez AM, Herrera F, Rodríguez‐Blanco J, Duarte‐Olivenza C, Turos‐Cabal M, Antolín I, Martín V. Regulation of cancer cell glucose metabolism is determinant for cancer cell fate after melatonin administration (2020). Review. J Cell Physiol. 236(1):27-40. doi: 10.1002/jcp.29886
43. Puente‑Moncada N, Turos‑Cabal M, Sánchez‑Sánchez AM, Antolín I, Herrera F, Rodriguez‑Blanco J, Duarte‑Olivenza C, Rodriguez C, Martín V (2020). Role of glucose metabolism in the differential antileukemic effect of melatonin on wild‑type and FLT3‑ITD mutant cells. Oncology Reports 44 (1), 293-302.
42. Letra-Vilela R#, Cardoso B#, Silva-Almeida C, Rocha AM, Murtinheira F, Branco-Santos J, Rodriguez C, Martin V, Santa-Marta M, Herrera F (2020). Can asymmetric post-translational modifications regulate the behavior of STAT3 homodimers? FASEB Bioadv. 2020 Jan 27;2(2):116-125. doi: 10.1096/fba.2019-00049. #, equal contribution.
41. Letra-Vilela, R.#, Quiteres, R.#, Murtinheira, F., Crevenna, A., Hensel, Z., Herrera F (2020). New tools for the visualization of glial fibrillary acidic protein in living cells. Experimental Results, 1, E4. doi:10.1017/exp.2020.1. #, equal contribution.
40. Herrera F*†, Branco-Santos J†, Outeiro TF* (2019). Threonine 3 regulates Serine 13/16 phosphorylation in the huntingtin exon 1. Sciencematters, doi: 10.19185/matters.201905000005.*, co-corresponding author; †, equal contribution.
39. Leitão MI, Herrera F, Petronilho A (2018). Anti-proliferative Activity of N-Heterocyclic Carbenes Derived from Guanosine. 10.26434/chemrxiv.6022919. ACS Omega 2018, 3, 11, 15653-15656.
38. Branco-Santos J, Herrera F*, Pires-Afonso Y, Poças GM, Giorgini F, Domingos PM*, and Outeiro TF* (2017). Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity. Hum Mol Genet. 2017 Oct 1;26(19):3763-3775. doi: 10.1093/hmg/ddx260. *, Co-corresponding author.
37. Letra-Vilela R, Sánchez-Sánchez AM, Rocha AM, Martin V, Branco-Santos J, Puente-Moncada N, Santa-Marta M, Outeiro TF, Antolín I, Rodriguez C and Herrera F (2016). Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin. Mol Cell Endocrinol. Oct 15;434:238-49.
36. Mesquita LM, Herrera F, Lamosa P, André V, Mateus P, Delgado R (2016). STAT3 inhibition by a dinuclear macrocyclic complex. Inorg Chem. 2016 Apr 4;55(7):3589-98.
35. Miranda HV, Gomes MA, Branco-Santos J, Breda C, Herrera F, Lopes LV, Giorgini F and Outeiro TF (2016). Glycation potentiates neurodegeneration in models of Huntington’s disease. Sci Rep. Nov 18;6:36798. doi: 10.1038/srep36798.
34. Poças GM, Branco-Santos J, Herrera F, Outeiro TF, Domingos PM. (2015) α-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila. Hum Mol Genet. 2015 Apr 1;24(7):1898-907. doi: 10.1093/hmg/ddu606.
33. Blum D, Herrera F, Francelle L, Mendes T, Basquin M, Obriot H, Demeyer D, Sergeant N, Gerhard E, Brouillet E, Buée L, Outeiro TF. (2015) Mutant huntingtin alters Tau phosphorylation and subcellular distribution. Hum Mol Genet. 2015 Jan 1;24(1):76-85. doi: 10.1093/hmg/ddu421.
32. Sajjad MU, Green EW, Hands S, Miller-Fleming L, Herrera F, Kyriacou CP, Faull R, Morton AJ, Jones L, Outeiro TF, Giorgini F, Wyttenbach A. (2014). DJ-1 modulates aggregation and pathogenesis in models of Huntington’s disease. Hum Mol Genet. 2014 Feb 1;23(3):755-66. doi: 10.1093/hmg/ddt466.
31.Martín V, Sanchez-Sanchez AM, Herrera F, Gomez-Manzano C, Fueyo J, Alvarez-Vega MA, Antolín I, Rodriguez C (2013). Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells. Br J Cancer. 2013 May 28;108(10):2005-12.
30.Rodriguez C, Martín V, Herrera F, García-Santos G, Rodriguez-Blanco J, Casado-Zapico S, Sánchez-Sánchez AM, Suárez S, Puente-Moncada N, Anítua MJ and Antolín I (2013). Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells. Int. J. Mol. Sci. 2013 Mar 25;14(4):6597-613. Review.
29.Amaral JD, Herrera F, Rodrigues PM, Dionísio PA, Outeiro TF, Rodrigues CM (2012). Live-cell imaging of p53 interactions using a novel Venus-based bimolecular fluorescence complementation system. Biochem Pharmacol. 2013 Mar 15;85(6):745-52.
28.Herrera F, Maher P, Schubert D (2012). c-Jun N-terminal kinase controls a negative loop in the regulation of glial fibrillary acidic protein expression by retinoic acid. Neuroscience. Apr 19;208:143-9.
27.Rodriguez-Blanco J, Martín V, García-Santos G, Herrera F, Casado-Zapico S, Antolín I, Rodriguez C (2012). Cooperative action of JNK and AKT/mTOR in 1-methyl-4-phenylpyridinium-induced autophagy of neuronal PC12 cells. J Neurosci Res. 2012 Sep;90(9):1850-60.
26.García-Santos G, Martin V, Rodríguez-Blanco J, Herrera F, Casado-Zapico S, Sánchez-Sánchez AM, Antolín I, Rodríguez C (2012). Fas/Fas ligand regulation mediates cell death in human Ewing’s sarcoma cells treated with melatonin. Br J Cancer. 2012 Mar 27;106(7):1288-96.
25.Herrera F, Gonçalves S, Outeiro TF (2012). Imaging protein oligomerization in neurodegeneration using bimolecular fluorescence complementation. Methods Enzymol. 2012; 506:157-74. Review.
24.Herrera F, Outeiro TF (2012). α-Synuclein modifies huntingtin aggregation in living cells. FEBS Lett. 2012 Jan 2;586(1):7-12. Epub 2011 Nov 24.
23.Badiola N, de Oliveira RM, Herrera F, Guardia-Laguarta C, Gonçalves SA, Pera M, Suárez-Calvet M, Clarimon J, Outeiro TF, Lleó A (2011). Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy. PLoS One. 2011;6(10):e26609. Epub 2011 Oct 24.
22.Herrera F, Tenreiro S, Miller-Fleming L, Outeiro TF (2011). Visualization of cell-to-cell transmission of mutant huntingtin oligomers. PLoS Curr. 2011 Feb 11; 3:RRN1210.
21.Herrera F, Chen Q, Schubert D (2010). Synergistic effect of retinoic acid and cytokines on the regulation of glial fibrillary acidic protein expression. J Biol Chem. 285(50):38915-22.
20.Herrera F, Chen Q, Fischer WH, Maher P, Schubert DR (2009). Synaptojanin-1 plays a key role in astrogliogenesis: possible relevance for Down’s syndrome. Cell Death Differ.16(6):910-20.
19.Schubert D, Herrera F, Cumming R, Read J, Low W, Maher P, Fischer WH (2009). Neural cells secrete a unique repertoire of proteins. J Neurochem. 109(2):427-35.
18.Rodriguez-Blanco J, Martin V, Herrera F, García-Santos G, Antolín I, Rodriguez C (2008). Intracellular signalling pathways involved in postmitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine. J Neurochem.107:127-140.
17.Martin V, Herrera F, Garcia-Santos G, Antolin I, Rodriguez-Blanco J, Rodriguez C (2007). Signaling pathways involved in antioxidant control of glioma cell proliferation. Free Radic Biol Med. 42:1715-1722.
16.Martin V, Herrera F, Garcia-Santos G, Antolin I, Rodriguez-Blanco J, Medina M. Rodriguez C (2007). Involvement of protein kinase C in melatonin’s oncostatic effect in C6 glioma cells. J Pineal Res. 43:239-244.
15.Carrera MP, Antolin I, Martin V, Sainz RM, Mayo JC, Herrera F, Garcia-Santos G, Rodriguez C (2007). Antioxidants do not prevent acrylonitrile-induced toxicity. Toxicol Lett.169:236-244.
14.Herrera F, Martin V, García-Santos G, Rodriguez-Blanco J, Antolín I, Rodriguez C (2007). Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria. J Neurochem. 100:736-746.
13.García-Santos G, Antolin I, Herrera F, Martin V, Rodriguez-Blanco J, Carrera MP, Rodriguez C (2006). Melatonin induces apoptosis in human neuroblastoma cancer cells. J Pineal Res. 41(2):130-135.
12.Herrera F, Martin V, Carrera P, García-Santos G, Rodriguez-Blanco J, Rodriguez C, Antolín I (2006). Tryptamine induces cell death with ultrastructural features of autophagy in neurons and glia: possible relevance for neurodegenerative disorders. Anat Rec A Discov Mol Cell Evol Biol. 288(9):1026-30.
11.Martin V, Herrera F, Carrera MP, García-Santos G, Antolín I, Rodriguez-Blanco J, Rodriguez C (2006). Intracellular signalling pathways involved in the cell growth inhibition of glioma cells by melatonin. Cancer Res. 66(2):1081-1088.
10.Herrera F, Martin V, García-Santos G, Rodriguez-Blanco J, Antolín I, Rodriguez C (2005). Intracellular redox state regulation by parthenolide. Biochem Biophys Res Comm. 332 : 321-325.
9.Herrera F., Martin V, Rodriguez-Blanco J, García-Santos G, Antolín I, Rodriguez C (2005). Standard curve for housekeeping and target genes: specific criteria for selection of loading control in northern blot analysis. J Biotech. 117: 337-341.
8.García-Santos G, Herrera F, Martin V, Rodriguez-Blanco J, Antolín I, Rodriguez C (2004). Antioxidant properties of zolpidem and its synthesis precursors in vitro and in a neuronal cell line. Free Rad Res. 38 (12): 1289-1299.
7.Herrera F, Mayo JC, Sáinz RM, Martin V, Antolín I, Rodriguez C (2004). Cytotoxicity and oncostatic activity of the thiazolidinedione derivative CGP52608 on central nervous system cancer cells. Cancer Lett. 211: 47-55.
6.Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, Reiter RJ (2004). Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res. 36(1): 1-9. Review.
5.Martin V, Sainz RM, Mayo JC, Antolin I, Herrera F, Rodriguez C (2003). Daily rhythm of gene expression in rat superoxide dismutases. Endocrine Res. 29(1): 83-95.
4.Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, Rodriguez C (2002). Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci. 59(10): 1706-1713.
3.Antolin I, Mayo JC, Sainz RM, Herrera F, Martin V, Rodriguez C (2002). Protective effect of melatonin in a chronic experimental model of Parkinson´s disease. Brain Res. 943(2): 163-173.
2.Martin V, Sainz RM, Antolin I, Mayo JC, Herrera F, Rodriguez C (2002). Several antioxidant pathways are involved in astrocyte protection by melatonin. J Pineal Res. 33: 204-212.
1.Herrera F, Sainz RM, Mayo JC, Martín V, Antolin I, Rodríguez C (2001). Glutamate induces oxidative stress not mediated by receptors or cystein transporters: protective effect of melatonin and other antioxidants. J Pineal Res. 31(4): 356-362.

Book Chapters

  • Herrera F, Gonçalves S, Branco-Santos J, Outeiro TF (2013). Studying the molecular determinants of oligomerization in neurodegenerative disorders by bimolecular fluorescence complementation within living cells. In: Bio-nanoimaging in protein misfolding and aggregation (Part 1, Chapter 19). Elsevier Inc. Editors: Vladimir N. Uversky and Yuri L. Lyubchenko.
  • Rodriguez C, Herrera F, Rodriguez-Blanco J, García-Santos G, Carrera MP, Antolin I, Sainz RM, Mayo JC, Martin V (2007). Melatonin: relationship with cell death. In: Melatonin: Present and future (Chapter 2; pp. 35-57). Nova Science Publishers. Editors: Pedro Montilla and Isaac Túnez.